Closed calls
The following Calls for proposals are now closed for proposals from applicant consortia. The resulting projects have been launched or are under development.
IMI2
- IMI2 - Call 16
Launched on 18 July 2018
Topics on antimicrobial resistance - IMI2 - Call 13
Launched on 30 November 2017
Topics on heart disease, inflammatory skin disease, antimicrobial resistance, neurodegenerative diseases, stem cells, mobility, cancer, toxicology, medicines safety, repurposing - IMI2 - Call 12
Launched on 19 July 2017
Topics on Alzheimer's disease, data, primary Sjögren’s Syndrome, vaccines, blood-brain barrier, European screening centre - IMI2 - Call 11
Launched on 19 July 2017
Topic on the exploitation of IMI project results - IMI2 - Call 10
Launched 21 December 2016
Topics on hypoglycaemia, big data and prostate cancer, pain, paediatric clinical trials, biomanufacturing, soluter carrier genes, patient perspectives, autism spectrum disorders
-
IMI2 - Call 9
Launched 27 April 2016
Topics on antimicrobial resistance, rheumatic diseases, data quality, medicines safety, liver disease, vaccines -
IMI2 - Call 8
Launched 18 December 2015
Topic on Ebola and related diseases -
IMI2 - Call 7
Launched 18 December 2015
Topics on medicines safety, Alzheimer's and Parkinson's diseases, pain, eye diseases, paediatric cancers, big data, heart disease and big data - IMI2 - Call 6
Launched 6 October 2015
Topics on medicines safety, infectious disease, big data and Alzheimer’s disease, big data and blood cancers -
IMI2 - Call 5
Launched 9 July 2015
Topics on benefits/risks, diabetes, dementia, patient engagement - IMI2 - Call 4
Launched 17 December 2014
Topic on medicines adaptive pathways to patients (MAPPs) - IMI2 - Call 3
Launched 17 December 2014
Topics on remote assessment of disease, diabetes, neuropsychiatry, vaccines, knowledge management -
IMI2 - Call 2
Launched 6 November 2014
Topics on Ebola and related diseases - IMI2 - Call 1
Launched 9 July 2014
Topics on diabetes and eye diseases
IMI1
-
IMI1 - Call 11
Launched 11 December 2013
Topics on osteoarthritis, dementia, cancer, infectious disease, drug discovery, antimicrobial resistance, environmental impacts -
IMI1 - Call 10
Launched 29 October 2013
Topic on vaccines -
IMI1 - Call 9
Launched 9 July 2013
Topics on pharmacovigilance, geriatric diseases, antimicrobial resistance -
IMI1 - Call 8
Launched 17 December 2012
Topics on antimicrobial resistance, stem cells, immune disorders, neurodegenerative disorders -
IMI1 - Call 7
Launched 17 July 2012
Topics on vaccines and real world data -
IMI1 - Call 6
Launched 24 May 2012
Topics on antimicrobial resistance -
IMI1 - Call 5
Launched 6 March 2012
Topics on European screening centre and joint compound collection -
IMI1 - Call 4
Launched 18 July 2011
Topics on knowledge management, diabetes, dementia, drug delivery, sustainable chemistry, stem cells, drug discovery - IMI1 - Call 3
Launched 22 October 2010
Topics on medicines safety, vaccines, tuberculosis, autism spectrum disorders, diabetes, patient education -
IMI1 - Call 2
Launched 27 November 2009
Topics on efficacy, cancer, infectious disease, immune disorders, knowledge management - IMI1 - Call 1
Launched 30 April 2008
Topics on medicines safety, efficacy, benefit/risk, diabetes, pain, brain disorders, respiratory disease, education and training